Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05994937 · ClinicalTrials.gov registry record · NA

Cleaner Air for Lower Cardiometabolic Risk

A NA study of PreDiabetes, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT05994937 is a NA study of PreDiabetes that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 160 participants, below the 689-participant average among 89 other PreDiabetes trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05994937, a NA study of PreDiabetes, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of this interventional sham-controlled pilot study is to study the effects of using portable air cleaners (PACs) in outpatient adults with prediabetes. The primary aims are to determine the effect PAC's have on glycemic variability and the concentrations of circulating biomarkers of inflammation.

Conditions Studied

Interventions

  • DEVICE PAC with HEPA filter intact
  • DEVICE PAC with HEPA filter removed

Study Locations (1)

New York

  • NYU Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2023-12-26
Est. Completion 2026-02-28
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05994937

The ClinicalTrials.gov registry entry for NCT05994937 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 689-participant average among 89 other PreDiabetes trials with a reported enrollment target (77% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which PAC with HEPA filter intact is the first listed.

NCT05994937 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05994937 about?

NCT05994937 is a clinical study titled "Cleaner Air for Lower Cardiometabolic Risk". The purpose of this interventional sham-controlled pilot study is to study the effects of using portable air cleaners (PACs) in outpatient adults with prediabetes. The primary aims are to determine the effect PAC's have on glycemic variability and the concentrations of circulating biomarkers of infl...

What is the current status of trial NCT05994937?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2023-12-26. Estimated completion is 2026-02-28.

What conditions does trial NCT05994937 study?

This clinical trial studies the following conditions: PreDiabetes.

What interventions are being tested in trial NCT05994937?

The interventions under investigation include: PAC with HEPA filter intact (DEVICE), PAC with HEPA filter removed (DEVICE).

Who is sponsoring clinical trial NCT05994937?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05994937 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.